Affirma Capital and StonePine, a private equity firms, agreed to acquire a majority stake in Nerhadou International, a pharmaceutical company, for $20m. “We are pleased to welcome aboard global investors such as Affirma Capital and StonePine to join us on our growth journey. Affirma and StonePine have been hands-on partners and have already helped us identify and execute on several value enhancement initiatives. We believe that their investment in Nerhadou will accelerate the company’s growth plans, solidify its market position, and bring the Company to IPO standards," Mohamed Shalaby, Nerhadou CEO.